WO2004007527A3 - Secreted proteins - Google Patents

Secreted proteins Download PDF

Info

Publication number
WO2004007527A3
WO2004007527A3 PCT/US2003/021576 US0321576W WO2004007527A3 WO 2004007527 A3 WO2004007527 A3 WO 2004007527A3 US 0321576 W US0321576 W US 0321576W WO 2004007527 A3 WO2004007527 A3 WO 2004007527A3
Authority
WO
WIPO (PCT)
Prior art keywords
secp
secreted proteins
polynucleotides
agonists
diagnosing
Prior art date
Application number
PCT/US2003/021576
Other languages
French (fr)
Other versions
WO2004007527A2 (en
Inventor
Amy E Kable
Anita Swarnakar
Soo Yeun Lee
Thomas W Richardson
Craig H Ison
Reena Khare
Pei Jin
Glenn K Fu
Shanya D Becha
Y Tom Tang
Vicki S Elliott
Bridget A Warren
Xin Jiang
Alan A Jackson
Mariah R Baughn
Brendan M Duggan
April J A Hafalia
Jayalaxmi Ramkumar
Uyen K Tran
Erika A Lindquist
Narinder K Chawla
Joseph P Marquis
Jonathan T Wang
Original Assignee
Incyte Corp
Amy E Kable
Anita Swarnakar
Soo Yeun Lee
Thomas W Richardson
Craig H Ison
Reena Khare
Pei Jin
Glenn K Fu
Shanya D Becha
Y Tom Tang
Vicki S Elliott
Bridget A Warren
Xin Jiang
Alan A Jackson
Mariah R Baughn
Brendan M Duggan
April J A Hafalia
Jayalaxmi Ramkumar
Uyen K Tran
Erika A Lindquist
Narinder K Chawla
Joseph P Marquis
Jonathan T Wang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Amy E Kable, Anita Swarnakar, Soo Yeun Lee, Thomas W Richardson, Craig H Ison, Reena Khare, Pei Jin, Glenn K Fu, Shanya D Becha, Y Tom Tang, Vicki S Elliott, Bridget A Warren, Xin Jiang, Alan A Jackson, Mariah R Baughn, Brendan M Duggan, April J A Hafalia, Jayalaxmi Ramkumar, Uyen K Tran, Erika A Lindquist, Narinder K Chawla, Joseph P Marquis, Jonathan T Wang filed Critical Incyte Corp
Priority to AU2003248933A priority Critical patent/AU2003248933A1/en
Publication of WO2004007527A2 publication Critical patent/WO2004007527A2/en
Publication of WO2004007527A3 publication Critical patent/WO2004007527A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human secreted proteins (SECP) and polynucleotides which identify and encode SECP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.
PCT/US2003/021576 2002-07-11 2003-07-10 Secreted proteins WO2004007527A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003248933A AU2003248933A1 (en) 2002-07-11 2003-07-10 Secreted proteins

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US39572202P 2002-07-11 2002-07-11
US60/395,722 2002-07-11
US39900302P 2002-07-26 2002-07-26
US60/399,003 2002-07-26
US40090902P 2002-08-01 2002-08-01
US60/400,909 2002-08-01
US40720202P 2002-08-30 2002-08-30
US40755202P 2002-08-30 2002-08-30
US60/407,202 2002-08-30
US60/407,552 2002-08-30

Publications (2)

Publication Number Publication Date
WO2004007527A2 WO2004007527A2 (en) 2004-01-22
WO2004007527A3 true WO2004007527A3 (en) 2007-10-11

Family

ID=30119455

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/021576 WO2004007527A2 (en) 2002-07-11 2003-07-10 Secreted proteins

Country Status (2)

Country Link
AU (1) AU2003248933A1 (en)
WO (1) WO2004007527A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252267B2 (en) 2005-03-30 2012-08-28 Sagres Discovery, Inc. DKKL-1 splice product modulators for cancer diagnosis and therapy
AU2007325872B2 (en) 2006-11-08 2012-12-13 Macrogenics West, Inc. TES7 and antibodies that bind thereto
AU2019261451A1 (en) * 2018-04-26 2020-12-03 Agenus Inc. Heat shock protein-binding peptide compositions and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518055B2 (en) * 2001-03-26 2003-02-11 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518055B2 (en) * 2001-03-26 2003-02-11 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

Also Published As

Publication number Publication date
WO2004007527A2 (en) 2004-01-22
AU2003248933A8 (en) 2004-02-02
AU2003248933A1 (en) 2004-02-02

Similar Documents

Publication Publication Date Title
WO2003027228A3 (en) Receptors and membrane-associated proteins
WO2002038602A3 (en) Secreted proteins
WO2003048305A3 (en) Receptors and membrane-associated proteins
WO2001098353A3 (en) Secreted proteins
WO2002048337A3 (en) Secreted human proteins
WO2003029437A3 (en) Secreted proteins
WO2002072794A3 (en) Immunoglobulin superfamily proteins
WO2001079291A3 (en) Secreted proteins
WO2003004615A3 (en) Secreted proteins
WO2003070902A3 (en) Receptors and membrane-associated proteins
WO2003068943A3 (en) Secreted proteins
WO2002070669A3 (en) Secreted proteins
WO2002086069A3 (en) Secreted proteins
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2004044165A3 (en) Lipid-associated proteins
WO2004048550A3 (en) Immune response associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2002026982A3 (en) Secreted human proteins
WO2003087300A3 (en) Secreted proteins
WO2003025130A3 (en) Receptors and membrane-associated proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003016506A3 (en) Secreted proteins
WO2002079441A3 (en) Secreted proteins
WO2003063769A3 (en) Vesicle-associated proteins
WO2001051636A3 (en) Secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP